Getting to value in healthcare has proven to be difficult, but succesful programs have certain characteristics, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
Getting to value in healthcare has proven to be difficult, but succesful programs have certain characteristics, said David Blumenthal, MD, MPP, president of The Commonwealth Fund.
Transcript
As the healthcare industry continues to move toward value-based care, what best practices have come to light?
Getting the value is hard we’ve discovered in a number of best practices. We think that when providers and payers are closely aligned, that there tends to be an environment in which value is easier to achieve. An example of those are Geissinger and Kaiser and Henry Ford. We’ve also found in our work on high-need, high-cost patients that there are certain characteristics of successful programs that manage that very important population that seem to be found in common among successful programs. For example, the use of information technology to inform care, the use of teams, engagement of patients and segmentation of patients to identify those who need different types of care. I think we’re making progress overall, there’s no question that it’s hard work and there’s a lot more work to do.
What are the biggest challenges you’ve seen in the move toward value-based care?
Well one is measurement. It’s hard to measure quality and controversy and burden associated with it and a recognition that sometimes the measures produce selection of patients that’s not good for high-risk patients and low income patients. That’s one important challenge. The other is getting past fee-for-service and getting to a place where accountability for cost and quality are married in the same organizations. And the third is getting those organizations to have the right sills and the right technology so they can effectively manage and be accountable for the candidate provide.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
5 Key Health Care Moments During President Trump's First Month Back in Office
February 21st 2025President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive orders affecting managed care, drug pricing, and clinical trial diversity guidance.
Read More
Adapting ACA Access Amid Medicaid Transition and Policy Reversals: Molly Dean
February 19th 2025As enrollment shifts to the Affordable Care Act (ACA) marketplace following the unwinding of Medicaid and the Trump administration begins to implement health policy changes, Molly Dean, MSW, Siftwell's policy advisor, shares insight on how to adapt.
Read More